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Abstract: 
 
Targeted imaging requires contrast agents that remain in the vasculature for extended periods of 
time. A new contrast agent is described in which gadolinium is encapsulated within an extremely 
stable carbon sphere, thus allowing for safe extended residence. Water solubility and small 
particle size is achieved with novel fullerene chemistry, attaching multiple oligoethylene glycol 
groups through nitrogen chemistry. These new compounds can be used to visualize tissue 
architecture in vivo with standard MRI techniques. 
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Article: 
 
Discoveries in molecular biology have produced an explosive growth in efforts to identify new 
targets for diagnostic medicine. However, imaging the distribution of validated targets in patients 
has lagged for want of safe, high-resolution imaging tools. Some nuclear medicine agents are 
targeted, but the relatively low resolution of PET/SPECT requires that these methods be 
combined with CT scans for interpretation, and there is concern about the long-term effects of 
exposure to ionizing radiation.(1) Magnetic resonance imaging (MRI) is widely available, highly 
translatable, and can provide high contrast, especially for the study of soft tissue. However, 
recent concerns over the role of current Gd-based contrast agents in the development of 
nephrogenic systemic fibrosis (NSF) in patients with impaired renal function(2, 3) highlight the 
need for safer imaging agents with enhanced imaging capabilities. In this report, we describe a 
new technology for improving MRI contrast based on endohedral metallofullerenes containing 
Gd. Surface modification of the fullerene provides much higher spin coupling with water protons 
than other forms of Gd despite separation by the fullerene cage. These nanomaterials are 
remarkably stable and hence are unlikely to release the Gd. These new nanomaterials injected 
intravenously demonstrate enhanced contrast in a mouse MRI, with circulation of at least 30 min. 
This technology could serve as a platform for developing agents that can specifically target 
molecular entities uniquely expressed on certain cells, tissues, or organs, thus providing 
caregivers improved ways to diagnose, treat, and monitor progression of a wide range of 
diseases. 
 
The fullerene-based nanomaterials described here may provide a unique platform for developing 
such technologies based on their enhanced relaxivity, stability, and ability to be derivatized with 
molecular targeting moieties. Endohedral metallofullerenes containing one Gd atom,(4, 
5) derivatized by polyhydroxylation or through addition of carboxyl groups to improve water 
solubility, exhibit high relaxivity, though the relaxivity has been attributed primarily to the 
formation of aggregates.(6, 7) This problem was overcome through chemistry that adds groups 
onto the fullerene cage that optimize magnetic coupling between the unpaired electrons on the 
enclosed paramagnetic Gd and water protons outside the cage. The cage is extremely stable; 
extreme oxidizing conditions are required to release gadolinium from the cage. 
 
The first trimetallic nitride MRI contrast agent, based on Gd3N@C80, was hydroxylated and 
PEGylated with long-chain glycols.(8) In the present work, we have synthesized(9) a series of 
novel derivatives of Gd3N@C80 termed Hydrochalarones (derived from χαλαρω = relax). These 
Hydrochalarones are not hydroxylated but are made water soluble by addition of a series of 
glycol methyl ethers, ranging from monoethylene glycol to hexaethylene glycol (Figure 1A). 
Importantly, the polar ethylene glycols are extremely close to the fullerene cage which increases 
its water solubility. The paramagnetic Gd atoms preclude using standard NMR to confirm the 
structure of these nanomaterials, but the number of attached groups can be inferred from 
thermogravimetric (TGA) analysis, where oxidation of the side chains takes place at a lower 
temperature than the cage. The TGA measurements on Gd3N@C80 and Hydrochalarones 
revealed the number of attachments on the cage to be 20−22, 12−14, and 10−12 for 
Hydrochalarone-1, -3, and -6, respectively. The connectivity between fullerene and glycol is not 
clear but likely includes RNOH and isoxazoline-like rings as inferred from their IR stretches 
(Figure 1B). 
 
 
Figure 1. (A) General structure of Hydrochalarones is Gd3N@C80-Rx, where R = 
−[N(OH)(CH2CH2O)nCH3]x where n = 1,3,6 and x is 10−22. (B) Infrared spectra of 
Hydrochalarone-6. 
 
It is known that a very stable species Gd3N@C80 is formed by combining two unstable species, 
Gd3N and C80. The Hydrochalarone derivatives are even more stable. For example, TGA shows 
Gd3N@C80 begins to oxidize at 180 °C and disintegrates very rapidly thereafter. By contrast, the 
Hydrochalarone cages start to decompose at ∼500 °C. Apparently the addition of polyethylene 
glycol groups stabilizes the carbon cage, presumably by relieving stress on the C═C bonds. 
Similarly, even heating in concentrated nitric acid at 80 °C for 4 h does not release the Gd atoms 
from the cage. Hydrochalarones are stable at room temperature for at least 6 months, monitored 
by relaxivity. 
 
The particle size of these nanomaterials was measured using DLS and found to be 10−15 nm, 
which is small enough to circulate through capillaries. Measurements of T1 relaxivity, r1, the 
standard metric of contrast enhancement, were performed on these nanomaterials in water using 
a 20 MHz Maran Ultra relaxometer (Oxford Instruments). The optimal member of this series, 
Hydrochalarone-6, has r1 of 205 mM−1 s−1 (68 mM−1 s−1 Gd, compared with 3.8 mM−1 s−1 for 
Magnevist, a commercial product containing Gd DTPA). Interestingly, the ratio of T2 relaxivity 
to T1 relaxivity, r2/r1, is comparable to those of the small Gd chelates, which is a critical factor in 
controlling signal intensity during T1-weighted MRI. 
 
Chelate-based MRI contrast agents, with one or more coordinated water molecules that exchange 
with bulk water molecules, exhibit a relaxivity described by the Solomon−Bloembergen−Morgan 
(SBM) equation.(10) In Hydrochalarone, the Gd atoms are entrapped in the cage and there is no 
possibility of water being coordinated to the paramagnetic metal centers. Thus, a different 
mechanism of spin transfer between Gd and water must be at work. 
 
Previous work on Gd@C60(OH)x and Gd@C60[C(COOHyNa1−y)2]10 implicated proton exchange 
from bulk water with hydroxyl and protonated malonate groups as integral to magnetic 
coupling.(4) Application of this hypothesis to Hydrochalarones can be tested by looking for 
−OH/−OD exchange in the FTIR spectrum. During deuterium exchange experiments no −OD 
stretches were observed, indicating that proton exchange cannot account for the relaxivity 
observed. 
 
The X-ray crystal structure shows that the Gd3N@C80 cage is slightly distorted by the entrapped 
Gd3N species and the Gd atoms are closer to the carbon atoms of the cage.(11)The unpaired f-
orbital electrons of the Gd atoms may interact with electrons in the molecular orbitals on the six-
carbon rings near the distortions. Water forms weak hydrogen bonds on benzene rings.(12) Gel 
electrophoresis shows that Hydrochalarones bear a negative charge that could enhance hydrogen 
bonding. Unpaired f-orbital electrons of Gd may couple their spins through the electrons on the 
carbon molecular orbitals to water protons that are hydrogen-bonded to the cage surface. This 
represents another example of “spin leakage”(13, 14) and supports the hypothesis that 
metallofullerenes behave as “superatoms.”(15)Hydrogen-bonded water molecules may act like 
inner-sphere water that rapidly exchange with many surrounding water molecules. Different 
length polyethylene glycol attachments may alter relaxivity by changing water diffusion rates 
through the hydration shells of the polyethylene glycol moieties. 
 
In vivo MRI studies were performed at 4.7 T using a small-animal scanner interfaced to a Varian 
INOVA console. Hydochalarone-6 was administered intravenously to a BALB/c mouse at a dose 
of 0.01 mmol/kg. (A typical clinical dose of commercial Gd-based MRI contrast agent is 0.1 
mmol/kg.) Figure 2 shows a coronal slice from a T1-weighted whole-body image of a mouse 
before and 30 min after Hydrochalarone administration. The persistent image enhancement of 
the aorta (arrow) indicates Hydrochalarone-6 remains in the vasculature, consistent with the 
observation that polyethylene glycol modifications increase the circulation time of proteins.(16) 
 
 
Figure 2. Coronal slice from a whole-body MRI of a mouse before (left) and 30 min after (right) 
administration of Hydrochalarone-6. The unidentified bright spot in both the pre- and 
postcontrast images is likely an artifact. 
 
In summary, Hydrochalarones are stable, appear well-tolerated in vivo, provide excellent MRI 
enhancement, and have “stealth” properties, meaning that rapid clearance mechanisms seem not 
to be triggered. These are desirable properties for the development of Hydrochalarones as 
imaging agent platforms upon which can be attached a broad range of targeting species for 
improved clinical diagnosis and management of a number of diseases. 
 
Supporting Information 
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